Premium
Ethanol Metabolites: Their Role in the Assessment of Alcohol Intake
Author(s) -
Wurst Friedrich M.,
Thon Natasha,
Yegles Michel,
Schrück Alexandra,
Preuss Ulrich W.,
Weinmann Wolfgang
Publication year - 2015
Publication title -
alcoholism: clinical and experimental research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.267
H-Index - 153
eISSN - 1530-0277
pISSN - 0145-6008
DOI - 10.1111/acer.12851
Subject(s) - ethyl glucuronide , phosphatidylethanol , carbohydrate deficient transferrin , alcohol , ethanol , biomarker , alcohol intake , medicine , ethyl ester , excessive alcohol consumption , alcohol consumption , pharmacology , physiology , chemistry , biochemistry , phospholipid , organic chemistry , membrane , phosphatidylcholine
Background Alcohol‐related disorders are common, expensive in their course, and often underdiagnosed. To facilitate early diagnosis and therapy of alcohol‐related disorders and to prevent later complications, questionnaires and biomarkers are useful. Methods Indirect state markers like gamma‐glutamyl‐transpeptidase, mean corpuscular volume, and carbohydrate deficient transferrin are influenced by age, gender, various substances, and nonalcohol‐related illnesses, and do not cover the entire timeline for alcohol consumption. Ethanol (EtOH) metabolites, such as ethyl glucuronide, ethyl sulfate, phosphatidylethanol, and fatty acid ethyl esters have gained enormous interest in the last decades as they are detectable after EtOH intake. Results For each biomarker, pharmacological characteristics, detection methods in different body tissues, sensitivity/specificity values, cutoff values, time frames of detection, and general limitations are presented. Another focus of the review is the use of the markers in special clinical and forensic samples. Conclusions Depending on the biological material used for analysis, ethanol metabolites can be applied in different settings such as assessment of alcohol intake, screening, prevention, diagnosis, and therapy of alcohol use disorders.